Preload Image
Preload Image
Report Store mobile icon
Global Genotyping Market Growth 2024-2030

Global Genotyping Market Growth 2024-2030

2024

Global Genotyping Market Growth 2024-2030

The global Genotyping market was valued at US$ 12.56 billion in 2024, driven by demand in personalized medicine and genetic testing.

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global genotyping market is experiencing significant growth, driven by advances in genomic technologies, the increasing prevalence of genetic disorders, and the rising demand for personalized medicine. Genotyping refers to the process of determining the genetic makeup of an individual by examining their DNA sequence. This technology is crucial in identifying genetic variations that can influence a person's risk of developing certain diseases, their response to medications, and their overall health. The market for genotyping is being propelled by the increasing adoption of next-generation sequencing (NGS) technologies, which offer high-throughput, cost-effective, and precise methods for analyzing genetic information. These technological advancements are enabling researchers and healthcare professionals to gain deeper insights into genetic diseases, drug interactions, and other health conditions, making genotyping an essential tool in modern healthcare and clinical research. The growing awareness of the benefits of genetic testing, combined with the rise of personalized medicine and precision healthcare, has led to a surge in demand for genotyping services. Additionally, the increasing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and genetic disorders, is further driving the adoption of genotyping technologies, as they help in early detection, risk assessment, and treatment planning. As the cost of sequencing continues to decrease and technologies become more accessible, the use of genotyping is expanding in clinical diagnostics, research, and biotechnology applications. The growing focus on genetic research in various fields, including pharmacogenomics, agriculture, and ancestry testing, is also contributing to the market’s growth. However, challenges such as ethical concerns, data privacy issues, and the need for skilled professionals to interpret complex genetic data may pose barriers to widespread adoption and growth in certain regions. Despite these challenges, the global genotyping market is poised for continued expansion, driven by ongoing innovations in genetic testing technologies and the increasing demand for personalized healthcare solutions.

According to Publisher, the global Genotyping market size was valued at US$ 12560 million in 2024. With growing demand in downstream market, the Genotyping is forecast to a readjusted size of US$ 27470 million by 2030 with a CAGR of 11.8% during review period. Geographically, the genotyping market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America holds a significant share of the market, with the United States being the largest contributor due to its advanced healthcare infrastructure, robust research and development capabilities, and high adoption of cutting-edge technologies. The presence of major players in the biotechnology and pharmaceutical industries, along with the growing emphasis on personalized medicine, has further bolstered the demand for genotyping services in the region. The U.S. government’s support for genomics research through initiatives such as the National Institutes of Health (NIH) and the All of Us program has accelerated the development and adoption of genotyping technologies in the country. Europe is another significant market, driven by the increasing awareness of genetic testing and the presence of leading healthcare providers, research institutions, and biotechnology companies. Countries such as Germany, the United Kingdom, and France are at the forefront of adopting genotyping technologies, fueled by the increasing demand for precision medicine and the growing focus on genomic research. The European Union's efforts to integrate genomic data into healthcare systems and promote personalized medicine are further contributing to market growth in the region. Asia-Pacific is expected to witness the highest growth in the coming years, with countries like China, Japan, and India emerging as key players in the genotyping market. The rapid growth of the healthcare and biotechnology sectors, along with the increasing investments in genomics research and the rising adoption of personalized medicine, are driving the demand for genotyping technologies in the region. Additionally, the expanding middle-class population, improving healthcare access, and the growing number of genetic disorders are further contributing to the market's expansion in Asia-Pacific. Latin America and the Middle East & Africa are expected to see moderate growth, as the adoption of advanced genetic testing technologies is gradually increasing due to improving healthcare infrastructure, rising awareness about genetic diseases, and the expansion of research initiatives in these regions.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample


The genotyping market is segmented based on technology, including DNA microarrays, polymerase chain reaction (PCR), next-generation sequencing (NGS), and others. NGS is the dominant technology, as it offers unparalleled throughput, speed, and accuracy in sequencing large volumes of genetic data. The decreasing cost of NGS and its ability to provide a comprehensive view of an individual’s genome have led to its widespread adoption in both research and clinical applications. NGS is particularly popular for whole-genome sequencing, targeted sequencing, and RNA sequencing, making it a versatile tool for a wide range of applications, from disease diagnosis to drug development. PCR is another widely used technology in genotyping, particularly for detecting specific genetic mutations or variations. PCR-based methods are highly sensitive, relatively inexpensive, and can be used for a variety of applications, including genotyping for single nucleotide polymorphisms (SNPs), gene expression analysis, and pathogen detection. DNA microarrays, although less commonly used than NGS and PCR, remain valuable for high-throughput genotyping applications, especially in large-scale genetic studies. They allow the simultaneous analysis of thousands of genetic markers, making them useful for identifying genetic variations associated with complex diseases. Other genotyping technologies, such as CRISPR-based methods and gene editing tools, are emerging as promising alternatives to traditional methods, offering higher precision and the ability to manipulate specific genetic sequences for research and therapeutic purposes. The continued advancements in these technologies, coupled with the increasing demand for faster and more accurate genetic testing, are expected to drive the growth of the genotyping market.

The genotyping market is also segmented by application into diagnostics, research, personalized medicine, and others. Diagnostics holds the largest share, as genotyping plays a crucial role in the identification and diagnosis of genetic disorders, infectious diseases, and cancer. Genetic testing is used to identify genetic mutations and variations that can predispose individuals to certain diseases, enabling early detection and personalized treatment plans. Genotyping technologies are also extensively used in prenatal and newborn screening, as well as in the detection of inherited diseases. Personalized medicine is another key application of genotyping, as genetic information helps in tailoring treatments to individual patients based on their genetic makeup. This approach is particularly valuable in oncology, where the identification of specific genetic mutations can help determine the most effective treatment options for cancer patients. Research is another significant application, with genotyping playing a pivotal role in studying genetic variations, disease mechanisms, and drug responses. Genomic research is critical in advancing our understanding of complex diseases and developing new therapies. Other applications of genotyping include agricultural biotechnology, where genetic testing is used to enhance crop breeding, and ancestry testing, which has gained popularity in recent years as consumers seek to understand their genetic heritage. The growing demand for personalized healthcare, along with the increasing awareness of genetic testing’s role in disease prevention and treatment, is expected to further drive the adoption of genotyping technologies across these diverse applications. As the technology continues to evolve and become more accessible, the potential for genotyping to revolutionize healthcare and other sectors remains vast.


Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Prashant Tiwari

Prashant Tiwari

Research Analyst



Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Prashant Tiwari

Table of Contents

  • 1 Scope of the Report
  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats
  • 2 Executive Summary
  • 2.1 World Market Overview
  • 2.1.1 Global Genotyping Annual Sales 2019-2030
  • 2.1.2 World Current & Future Analysis for Genotyping by Geographic Region, 2019, 2023 & 2030
  • 2.1.3 World Current & Future Analysis for Genotyping by Country/Region, 2019, 2023 & 2030
  • 2.2 Genotyping Segment by Type
  • 2.2.1 Polymerase Chain Reaction
  • 2.2.2 Sequencing
  • 2.2.3 Microarray
  • 2.2.4 Electrophoresis
  • 2.2.5 MALDI-TOF
  • 2.3 Genotyping Sales by Type
  • 2.3.1 Global Genotyping Sales Market Share by Type (2019-2024)
  • 2.3.2 Global Genotyping Revenue and Market Share by Type (2019-2024)
  • 2.3.3 Global Genotyping Sale Price by Type (2019-2024)
  • 2.4 Genotyping Segment by Application
  • 2.4.1 Pharmacogenomics
  • 2.4.2 Diagnostic Research
  • 2.4.3 Animal Genetics
  • 2.4.4 Agricultural Biotechnology
  • 2.5 Genotyping Sales by Application
  • 2.5.1 Global Genotyping Sale Market Share by Application (2019-2024)
  • 2.5.2 Global Genotyping Revenue and Market Share by Application (2019-2024)
  • 2.5.3 Global Genotyping Sale Price by Application (2019-2024)
  • 3 Global Genotyping by Company
  • 3.1 Global Genotyping Breakdown Data by Company
  • 3.1.1 Global Genotyping Annual Sales by Company (2019-2024)
  • 3.1.2 Global Genotyping Sales Market Share by Company (2019-2024)
  • 3.2 Global Genotyping Annual Revenue by Company (2019-2024)
  • 3.2.1 Global Genotyping Revenue by Company (2019-2024)
  • 3.2.2 Global Genotyping Revenue Market Share by Company (2019-2024)
  • 3.3 Global Genotyping Sale Price by Company
  • 3.4 Key Manufacturers Genotyping Producing Area Distribution, Sales Area, Product Type
  • 3.4.1 Key Manufacturers Genotyping Product Location Distribution
  • 3.4.2 Players Genotyping Products Offered
  • 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for Genotyping by Geographic Region
  • 4.1 World Historic Genotyping Market Size by Geographic Region (2019-2024)
  • 4.1.1 Global Genotyping Annual Sales by Geographic Region (2019-2024)
  • 4.1.2 Global Genotyping Annual Revenue by Geographic Region (2019-2024)
  • 4.2 World Historic Genotyping Market Size by Country/Region (2019-2024)
  • 4.2.1 Global Genotyping Annual Sales by Country/Region (2019-2024)
  • 4.2.2 Global Genotyping Annual Revenue by Country/Region (2019-2024)
  • 4.3 Americas Genotyping Sales Growth
  • 4.4 APAC Genotyping Sales Growth
  • 4.5 Europe Genotyping Sales Growth
  • 4.6 Middle East & Africa Genotyping Sales Growth
  • 5 Americas
  • 5.1 Americas Genotyping Sales by Country
  • 5.1.1 Americas Genotyping Sales by Country (2019-2024)
  • 5.1.2 Americas Genotyping Revenue by Country (2019-2024)
  • 5.2 Americas Genotyping Sales by Type
  • 5.3 Americas Genotyping Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil
  • 6 APAC
  • 6.1 APAC Genotyping Sales by Region
  • 6.1.1 APAC Genotyping Sales by Region (2019-2024)
  • 6.1.2 APAC Genotyping Revenue by Region (2019-2024)
  • 6.2 APAC Genotyping Sales by Type
  • 6.3 APAC Genotyping Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan
  • 7 Europe
  • 7.1 Europe Genotyping by Country
  • 7.1.1 Europe Genotyping Sales by Country (2019-2024)
  • 7.1.2 Europe Genotyping Revenue by Country (2019-2024)
  • 7.2 Europe Genotyping Sales by Type
  • 7.3 Europe Genotyping Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia
  • 8 Middle East & Africa
  • 8.1 Middle East & Africa Genotyping by Country
  • 8.1.1 Middle East & Africa Genotyping Sales by Country (2019-2024)
  • 8.1.2 Middle East & Africa Genotyping Revenue by Country (2019-2024)
  • 8.2 Middle East & Africa Genotyping Sales by Type
  • 8.3 Middle East & Africa Genotyping Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends
  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis
  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Genotyping
  • 10.3 Manufacturing Process Analysis of Genotyping
  • 10.4 Industry Chain Structure of Genotyping
  • 11 Marketing, Distributors and Customer
  • 11.1 Sales Channel
  • 11.1.1 Direct Channels
  • 11.1.2 Indirect Channels
  • 11.2 Genotyping Distributors
  • 11.3 Genotyping Customer
  • 12 World Forecast Review for Genotyping by Geographic Region
  • 12.1 Global Genotyping Market Size Forecast by Region
  • 12.1.1 Global Genotyping Forecast by Region (2025-2030)
  • 12.1.2 Global Genotyping Annual Revenue Forecast by Region (2025-2030)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Genotyping Forecast by Type
  • 12.7 Global Genotyping Forecast by Application
  • 13 Key Players Analysis
  • 13.1 Illumina
  • 13.1.1 Illumina Company Information
  • 13.1.2 Illumina Genotyping Product Portfolios and Specifications
  • 13.1.3 Illumina Genotyping Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.1.4 Illumina Main Business Overview
  • 13.1.5 Illumina Latest Developments
  • 13.2 Affymetrix
  • 13.2.1 Affymetrix Company Information
  • 13.2.2 Affymetrix Genotyping Product Portfolios and Specifications
  • 13.2.3 Affymetrix Genotyping Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.2.4 Affymetrix Main Business Overview
  • 13.2.5 Affymetrix Latest Developments
  • 13.3 Life Technologies
  • 13.3.1 Life Technologies Company Information
  • 13.3.2 Life Technologies Genotyping Product Portfolios and Specifications
  • 13.3.3 Life Technologies Genotyping Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.3.4 Life Technologies Main Business Overview
  • 13.3.5 Life Technologies Latest Developments
  • 13.4 Agilent Technologies
  • 13.4.1 Agilent Technologies Company Information
  • 13.4.2 Agilent Technologies Genotyping Product Portfolios and Specifications
  • 13.4.3 Agilent Technologies Genotyping Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.4.4 Agilent Technologies Main Business Overview
  • 13.4.5 Agilent Technologies Latest Developments
  • 13.5 Qiagen
  • 13.5.1 Qiagen Company Information
  • 13.5.2 Qiagen Genotyping Product Portfolios and Specifications
  • 13.5.3 Qiagen Genotyping Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.5.4 Qiagen Main Business Overview
  • 13.5.5 Qiagen Latest Developments
  • 13.6 Sequenom
  • 13.6.1 Sequenom Company Information
  • 13.6.2 Sequenom Genotyping Product Portfolios and Specifications
  • 13.6.3 Sequenom Genotyping Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.6.4 Sequenom Main Business Overview
  • 13.6.5 Sequenom Latest Developments
  • 13.7 Fluidigm
  • 13.7.1 Fluidigm Company Information
  • 13.7.2 Fluidigm Genotyping Product Portfolios and Specifications
  • 13.7.3 Fluidigm Genotyping Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.7.4 Fluidigm Main Business Overview
  • 13.7.5 Fluidigm Latest Developments
  • 13.8 Beckman Coulter
  • 13.8.1 Beckman Coulter Company Information
  • 13.8.2 Beckman Coulter Genotyping Product Portfolios and Specifications
  • 13.8.3 Beckman Coulter Genotyping Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.8.4 Beckman Coulter Main Business Overview
  • 13.8.5 Beckman Coulter Latest Developments
  • 13.9 Roche
  • 13.9.1 Roche Company Information
  • 13.9.2 Roche Genotyping Product Portfolios and Specifications
  • 13.9.3 Roche Genotyping Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.9.4 Roche Main Business Overview
  • 13.9.5 Roche Latest Developments
  • 13.10 GE Healthcare
  • 13.10.1 GE Healthcare Company Information
  • 13.10.2 GE Healthcare Genotyping Product Portfolios and Specifications
  • 13.10.3 GE Healthcare Genotyping Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.10.4 GE Healthcare Main Business Overview
  • 13.10.5 GE Healthcare Latest Developments
  • 14 Research Findings and Conclusion


Table 1. Genotyping Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Genotyping Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Polymerase Chain Reaction
Table 4. Major Players of Sequencing
Table 5. Major Players of Microarray
Table 6. Major Players of Electrophoresis
Table 7. Major Players of MALDI-TOF
Table 8. Global Genotyping Sales by Type (2019-2024) & (K Units)
Table 9. Global Genotyping Sales Market Share by Type (2019-2024)
Table 10. Global Genotyping Revenue by Type (2019-2024) & ($ million)
Table 11. Global Genotyping Revenue Market Share by Type (2019-2024)
Table 12. Global Genotyping Sale Price by Type (2019-2024) & (USD/Unit)
Table 13. Global Genotyping Sales by Application (2019-2024) & (K Units)
Table 14. Global Genotyping Sales Market Share by Application (2019-2024)
Table 15. Global Genotyping Revenue by Application (2019-2024)
Table 16. Global Genotyping Revenue Market Share by Application (2019-2024)
Table 17. Global Genotyping Sale Price by Application (2019-2024) & (USD/Unit)
Table 18. Global Genotyping Sales by Company (2019-2024) & (K Units)
Table 19. Global Genotyping Sales Market Share by Company (2019-2024)
Table 20. Global Genotyping Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Genotyping Revenue Market Share by Company (2019-2024)
Table 22. Global Genotyping Sale Price by Company (2019-2024) & (USD/Unit)
Table 23. Key Manufacturers Genotyping Producing Area Distribution and Sales Area
Table 24. Players Genotyping Products Offered
Table 25. Genotyping Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Genotyping Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Genotyping Sales Market Share Geographic Region (2019-2024)
Table 30. Global Genotyping Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Genotyping Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Genotyping Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Genotyping Sales Market Share by Country/Region (2019-2024)
Table 34. Global Genotyping Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Genotyping Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Genotyping Sales by Country (2019-2024) & (K Units)
Table 37. Americas Genotyping Sales Market Share by Country (2019-2024)
Table 38. Americas Genotyping Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Genotyping Revenue Market Share by Country (2019-2024)
Table 40. Americas Genotyping Sales by Type (2019-2024) & (K Units)
Table 41. Americas Genotyping Sales by Application (2019-2024) & (K Units)
Table 42. APAC Genotyping Sales by Region (2019-2024) & (K Units)
Table 43. APAC Genotyping Sales Market Share by Region (2019-2024)
Table 44. APAC Genotyping Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Genotyping Revenue Market Share by Region (2019-2024)
Table 46. APAC Genotyping Sales by Type (2019-2024) & (K Units)
Table 47. APAC Genotyping Sales by Application (2019-2024) & (K Units)
Table 48. Europe Genotyping Sales by Country (2019-2024) & (K Units)
Table 49. Europe Genotyping Sales Market Share by Country (2019-2024)
Table 50. Europe Genotyping Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Genotyping Revenue Market Share by Country (2019-2024)
Table 52. Europe Genotyping Sales by Type (2019-2024) & (K Units)
Table 53. Europe Genotyping Sales by Application (2019-2024) & (K Units)
Table 54. Middle East & Africa Genotyping Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa Genotyping Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Genotyping Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Genotyping Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Genotyping Sales by Type (2019-2024) & (K Units)
Table 59. Middle East & Africa Genotyping Sales by Application (2019-2024) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Genotyping
Table 61. Key Market Challenges & Risks of Genotyping
Table 62. Key Industry Trends of Genotyping
Table 63. Genotyping Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Genotyping Distributors List
Table 66. Genotyping Customer List
Table 67. Global Genotyping Sales Forecast by Region (2025-2030) & (K Units)
Table 68. Global Genotyping Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Genotyping Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Americas Genotyping Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Genotyping Sales Forecast by Region (2025-2030) & (K Units)
Table 72. APAC Genotyping Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Genotyping Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Europe Genotyping Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Genotyping Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Middle East & Africa Genotyping Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Genotyping Sales Forecast by Type (2025-2030) & (K Units)
Table 78. Global Genotyping Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Genotyping Sales Forecast by Application (2025-2030) & (K Units)
Table 80. Global Genotyping Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Illumina Basic Information, Genotyping Manufacturing Base, Sales Area and Its Competitors
Table 82. Illumina Genotyping Product Portfolios and Specifications
Table 83. Illumina Genotyping Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Illumina Main Business
Table 85. Illumina Latest Developments
Table 86. Affymetrix Basic Information, Genotyping Manufacturing Base, Sales Area and Its Competitors
Table 87. Affymetrix Genotyping Product Portfolios and Specifications
Table 88. Affymetrix Genotyping Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Affymetrix Main Business
Table 90. Affymetrix Latest Developments
Table 91. Life Technologies Basic Information, Genotyping Manufacturing Base, Sales Area and Its Competitors
Table 92. Life Technologies Genotyping Product Portfolios and Specifications
Table 93. Life Technologies Genotyping Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Life Technologies Main Business
Table 95. Life Technologies Latest Developments
Table 96. Agilent Technologies Basic Information, Genotyping Manufacturing Base, Sales Area and Its Competitors
Table 97. Agilent Technologies Genotyping Product Portfolios and Specifications
Table 98. Agilent Technologies Genotyping Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Agilent Technologies Main Business
Table 100. Agilent Technologies Latest Developments
Table 101. Qiagen Basic Information, Genotyping Manufacturing Base, Sales Area and Its Competitors
Table 102. Qiagen Genotyping Product Portfolios and Specifications
Table 103. Qiagen Genotyping Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Qiagen Main Business
Table 105. Qiagen Latest Developments
Table 106. Sequenom Basic Information, Genotyping Manufacturing Base, Sales Area and Its Competitors
Table 107. Sequenom Genotyping Product Portfolios and Specifications
Table 108. Sequenom Genotyping Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Sequenom Main Business
Table 110. Sequenom Latest Developments
Table 111. Fluidigm Basic Information, Genotyping Manufacturing Base, Sales Area and Its Competitors
Table 112. Fluidigm Genotyping Product Portfolios and Specifications
Table 113. Fluidigm Genotyping Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Fluidigm Main Business
Table 115. Fluidigm Latest Developments
Table 116. Beckman Coulter Basic Information, Genotyping Manufacturing Base, Sales Area and Its Competitors
Table 117. Beckman Coulter Genotyping Product Portfolios and Specifications
Table 118. Beckman Coulter Genotyping Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Beckman Coulter Main Business
Table 120. Beckman Coulter Latest Developments
Table 121. Roche Basic Information, Genotyping Manufacturing Base, Sales Area and Its Competitors
Table 122. Roche Genotyping Product Portfolios and Specifications
Table 123. Roche Genotyping Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Roche Main Business
Table 125. Roche Latest Developments
Table 126. GE Healthcare Basic Information, Genotyping Manufacturing Base, Sales Area and Its Competitors
Table 127. GE Healthcare Genotyping Product Portfolios and Specifications
Table 128. GE Healthcare Genotyping Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. GE Healthcare Main Business
Table 130. GE Healthcare Latest Developments
List of


Figure 1. Picture of Genotyping
Figure 2. Genotyping Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Genotyping Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Genotyping Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Genotyping Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Polymerase Chain Reaction
Figure 10. Product Picture of Sequencing
Figure 11. Product Picture of Microarray
Figure 12. Product Picture of Electrophoresis
Figure 13. Product Picture of MALDI-TOF
Figure 14. Global Genotyping Sales Market Share by Type in 2023
Figure 15. Global Genotyping Revenue Market Share by Type (2019-2024)
Figure 16. Genotyping Consumed in Pharmacogenomics
Figure 17. Global Genotyping Market: Pharmacogenomics (2019-2024) & (K Units)
Figure 18. Genotyping Consumed in Diagnostic Research
Figure 19. Global Genotyping Market: Diagnostic Research (2019-2024) & (K Units)
Figure 20. Genotyping Consumed in Animal Genetics
Figure 21. Global Genotyping Market: Animal Genetics (2019-2024) & (K Units)
Figure 22. Genotyping Consumed in Agricultural Biotechnology
Figure 23. Global Genotyping Market: Agricultural Biotechnology (2019-2024) & (K Units)
Figure 24. Global Genotyping Sales Market Share by Application (2023)
Figure 25. Global Genotyping Revenue Market Share by Application in 2023
Figure 26. Genotyping Sales Market by Company in 2023 (K Units)
Figure 27. Global Genotyping Sales Market Share by Company in 2023
Figure 28. Genotyping Revenue Market by Company in 2023 ($ Million)
Figure 29. Global Genotyping Revenue Market Share by Company in 2023
Figure 30. Global Genotyping Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global Genotyping Revenue Market Share by Geographic Region in 2023
Figure 32. Americas Genotyping Sales 2019-2024 (K Units)
Figure 33. Americas Genotyping Revenue 2019-2024 ($ Millions)
Figure 34. APAC Genotyping Sales 2019-2024 (K Units)
Figure 35. APAC Genotyping Revenue 2019-2024 ($ Millions)
Figure 36. Europe Genotyping Sales 2019-2024 (K Units)
Figure 37. Europe Genotyping Revenue 2019-2024 ($ Millions)
Figure 38. Middle East & Africa Genotyping Sales 2019-2024 (K Units)
Figure 39. Middle East & Africa Genotyping Revenue 2019-2024 ($ Millions)
Figure 40. Americas Genotyping Sales Market Share by Country in 2023
Figure 41. Americas Genotyping Revenue Market Share by Country in 2023
Figure 42. Americas Genotyping Sales Market Share by Type (2019-2024)
Figure 43. Americas Genotyping Sales Market Share by Application (2019-2024)
Figure 44. United States Genotyping Revenue Growth 2019-2024 ($ Millions)
Figure 45. Canada Genotyping Revenue Growth 2019-2024 ($ Millions)
Figure 46. Mexico Genotyping Revenue Growth 2019-2024 ($ Millions)
Figure 47. Brazil Genotyping Revenue Growth 2019-2024 ($ Millions)
Figure 48. APAC Genotyping Sales Market Share by Region in 2023
Figure 49. APAC Genotyping Revenue Market Share by Regions in 2023
Figure 50. APAC Genotyping Sales Market Share by Type (2019-2024)
Figure 51. APAC Genotyping Sales Market Share by Application (2019-2024)
Figure 52. China Genotyping Revenue Growth 2019-2024 ($ Millions)
Figure 53. Japan Genotyping Revenue Growth 2019-2024 ($ Millions)
Figure 54. South Korea Genotyping Revenue Growth 2019-2024 ($ Millions)
Figure 55. Southeast Asia Genotyping Revenue Growth 2019-2024 ($ Millions)
Figure 56. India Genotyping Revenue Growth 2019-2024 ($ Millions)
Figure 57. Australia Genotyping Revenue Growth 2019-2024 ($ Millions)
Figure 58. China Taiwan Genotyping Revenue Growth 2019-2024 ($ Millions)
Figure 59. Europe Genotyping Sales Market Share by Country in 2023
Figure 60. Europe Genotyping Revenue Market Share by Country in 2023
Figure 61. Europe Genotyping Sales Market Share by Type (2019-2024)
Figure 62. Europe Genotyping Sales Market Share by Application (2019-2024)
Figure 63. Germany Genotyping Revenue Growth 2019-2024 ($ Millions)
Figure 64. France Genotyping Revenue Growth 2019-2024 ($ Millions)
Figure 65. UK Genotyping Revenue Growth 2019-2024 ($ Millions)
Figure 66. Italy Genotyping Revenue Growth 2019-2024 ($ Millions)
Figure 67. Russia Genotyping Revenue Growth 2019-2024 ($ Millions)
Figure 68. Middle East & Africa Genotyping Sales Market Share by Country in 2023
Figure 69. Middle East & Africa Genotyping Revenue Market Share by Country in 2023
Figure 70. Middle East & Africa Genotyping Sales Market Share by Type (2019-2024)
Figure 71. Middle East & Africa Genotyping Sales Market Share by Application (2019-2024)
Figure 72. Egypt Genotyping Revenue Growth 2019-2024 ($ Millions)
Figure 73. South Africa Genotyping Revenue Growth 2019-2024 ($ Millions)
Figure 74. Israel Genotyping Revenue Growth 2019-2024 ($ Millions)
Figure 75. Turkey Genotyping Revenue Growth 2019-2024 ($ Millions)
Figure 76. GCC Country Genotyping Revenue Growth 2019-2024 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Genotyping in 2023
Figure 78. Manufacturing Process Analysis of Genotyping
Figure 79. Industry Chain Structure of Genotyping
Figure 80. Channels of Distribution
Figure 81. Global Genotyping Sales Market Forecast by Region (2025-2030)
Figure 82. Global Genotyping Revenue Market Share Forecast by Region (2025-2030)
Figure 83. Global Genotyping Sales Market Share Forecast by Type (2025-2030)
Figure 84. Global Genotyping Revenue Market Share Forecast by Type (2025-2030)
Figure 85. Global Genotyping Sales Market Share Forecast by Application (2025-2030)
Figure 86. Global Genotyping Revenue Market Share Forecast by Application (2025-2030)

Related Tags

Related Reports

payment cards

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted

Quick Contacts

Want to customize this report?

We offer 10% Free Customization at the time of purchase

Get Free Customization

I'm Available

Raj Shrivastava

Raj Shrivastava

Business Development Manager

Trusted Partners

NONWOVENS_INDUSTRY
FB
issuewire
Financial_Express
logo_yourstory
FB

Budget constraints? Get in touch with us for special pricing

Request Discount

Order Detail

  • Order Placed (09 May, 2026)
  • Notify To Team (09 May, 2026)
  • Report updation (10 May, 2026)
  • Report Quality Check (10 May, 2026)
  • Report Dispatch (11 May, 2026)

  • paypal
  • icici
  • stripe
  • wire-transfer

  • Email
  • Hard Copy

Research Methodology

An Adaptive Approach to Modern-day Research Needs

Get Methodology

Recently Viewed Products

Logo

Global Genotyping Market Growth 2024-2030

ChatGPT Summarize Gemini Summarize Perplexity AI Summarize Grok AI Summarize Copilot Summarize

Contact usWe are friendly and approachable, give us a call.

We uses Cookies

We use cookies to ensure you get the best experience on our website.